These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 1913698)
1. Characterisation of the in vivo behaviour of a controlled-release formulation of levodopa (Sinemet CR). Wilding IR; Hardy JG; Davis SS; Melia CD; Evans DF; Short AH; Sparrow RA; Yeh KC Clin Neuropharmacol; 1991 Aug; 14(4):305-21. PubMed ID: 1913698 [TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal transit of Sinemet CR in healthy volunteers. Wilding IR; Davis SS; Melia CD; Hardy JG; Evans DF; Short AH; Sparrow RA Neurology; 1989 Nov; 39(11 Suppl 2):53-8. PubMed ID: 2685651 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies. Yeh KC; August TF; Bush DF; Lasseter KC; Musson DG; Schwartz S; Smith ME; Titus DC Neurology; 1989 Nov; 39(11 Suppl 2):25-38. PubMed ID: 2685649 [TBL] [Abstract][Full Text] [Related]
5. A pharmacokinetic and pharmacodynamic comparison of Sinemet CR (50/200) and standard Sinemet (25/100). Cedarbaum JM; Kutt H; McDowell FH Neurology; 1989 Nov; 39(11 Suppl 2):38-44; discussion 59. PubMed ID: 2586762 [TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical design and development of a Sinemet controlled-release formulation. Dempski RE; Scholtz EC; Oberholtzer ER; Yeh KC Neurology; 1989 Nov; 39(11 Suppl 2):20-4. PubMed ID: 2685648 [TBL] [Abstract][Full Text] [Related]
7. The influence of a standard meal on Sinemet CR absorption in patients with Parkinson's disease. Roos RA; Tijssen MA; van der Velde EA; Breimer DD Clin Neurol Neurosurg; 1993 Sep; 95(3):215-9. PubMed ID: 8242964 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of levodopa/carbidopa delivered from gastric-retentive extended-release formulations in patients with Parkinson's disease. Chen C; Cowles VE; Sweeney M; Stolyarov ID; Illarioshkin SN J Clin Pharmacol; 2012 Jul; 52(7):1069-77. PubMed ID: 21610205 [TBL] [Abstract][Full Text] [Related]
18. Bioavailability studies of oral dosage forms containing levodopa and carbidopa using column-switching chromatography followed by electrochemical detection. Sagar KA; Smyth MR Analyst; 2000 Mar; 125(3):439-45. PubMed ID: 10829343 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Sinemet CR4 and standard Sinemet: double blind and long-term open trial in parkinsonian patients with fluctuations. Jankovic J; Schwartz K; Vander Linden C Mov Disord; 1989; 4(4):303-9. PubMed ID: 2682215 [TBL] [Abstract][Full Text] [Related]
20. Controlled-release carbidopa/levodopa (CR) in parkinsonian patients with response fluctuations on standard levodopa treatment: clinical and pharmacokinetic observations. Deleu D; Jacques M; Michotte Y; Ebinger G Neurology; 1989 Nov; 39(11 Suppl 2):88-92; discussion 95. PubMed ID: 2685654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]